IBIO, INC. Form DEF 14A: Definitive proxy statement
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-09-04: Form DEF 14A; Period of report 2026-09-04; Description DEF 14A; Document ibio-20260904xdef14a.htm.
- 2025-10-06: Form DEF 14A; Period of report 2025-11-20; Description DEF 14A; Document ibio-20251120xdef14a.htm.
- 2024-10-10: Form DEF 14A; Period of report 2024-10-10; Description DEF 14A; Document tmb-20241010xdef14a.htm.
- 2023-10-26: Form DEF 14A; Period of report 2023-11-27; Description DEF 14A; Document tmb-20231127xdef14a.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-09-04 | DEF 14A | 2026-09-04 | DEF 14A | ibio-20260904xdef14a.htm |
| 2025-10-06 | DEF 14A | 2025-11-20 | DEF 14A | ibio-20251120xdef14a.htm |
| 2024-10-10 | DEF 14A | 2024-10-10 | DEF 14A | tmb-20241010xdef14a.htm |
| 2023-10-26 | DEF 14A | 2023-11-27 | DEF 14A | tmb-20231127xdef14a.htm |
| 2022-10-26 | DEF 14A | 2022-12-08 | DEF 14A | tmb-20221208xdef14a.htm |
| 2022-05-24 | DEF 14A | 2022-06-30 | DEF 14A | tmb-20220630xdef14a.htm |
| 2021-10-26 | DEF 14A | 2021-12-09 | DEF 14A | tm2129710-2_def14a.htm |
| 2020-11-03 | DEF 14A | 2020-12-09 | DEF 14A | tm2034104d2_def14a.htm |
| 2020-01-23 | DEF 14A | 2020-02-10 | DEF 14A | tv536232-def14a.htm |
| 2018-11-19 | DEF 14A | 2018-12-18 | DEFINITIVE PROXY STATEMENT | tv506934-def14a.htm |
| 2018-04-03 | DEF 14A | 2018-04-23 | DEF 14A | tv490229_def14a.htm |
| 2017-11-27 | DEF 14A | 2017-12-19 | DEF 14A | tv480237_def14a.htm |
| 2017-04-06 | DEF 14A | 2017-05-04 | DEF 14A | v463693_def14a.htm |
| 2016-03-11 | DEF 14A | 2016-04-07 | DEF 14A | v433064_def14a.htm |
| 2014-11-12 | DEF 14A | 2014-12-10 | DEF 14A | v393757_def14a.htm |
| 2013-11-18 | DEF 14A | 2013-12-17 | DEF 14A | v360720_def14a.htm |
| 2012-11-16 | DEF 14A | 2012-12-18 | Definitive proxy statement | c71606_def14a.htm |
| 2011-11-08 | DEF 14A | 2011-12-08 | Definitive proxy statement | c67405_def14a.htm |
| 2010-11-10 | DEF 14A | 2010-12-09 | Definitive proxy statement | c63165_def14a.htm |
| 2009-10-28 | DEF 14A | 2009-12-16 | Definitive proxy statement | c59185_def14a.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |